Pharma Pulse 4/12/24: The Road Ahead for GenAI-Enabled/Augmented Clinical Trials, The Health and Healthcare of Boomers & more


The latest news for pharma industry insiders.

Generative AI-Enabled/Augmented Clinical Trials: The Road Ahead

The current clinical development model is shifting toward a generative AI-augmented proactive approach supported by real-world data for real time evidence.

Talking About the Generations: The Health and Healthcare of Boomers, Gen Xers, Millennials and Gen Zers. Part 1, The Boomers

Tne Boomers (1946–1964): Active but aging

Kenvue Revamps Cyber Tools After Spinoff From J&J

The consumer-health company saw a surge in scams targeting employees around the time of its separation from Johnson & Johnson last year

Thermo Fisher Scientific Introduces Animal Origin-Free Formulation to Support Scaling of Cell Therapy Manufacturing

Breakthrough medium delivers speed and scale to CAR-T cell therapy manufacturers

Kevin L. Hagan on LinkedIn:

I invite everyone to watch or read part one of the recent Pharmaceutical Commerce Magazine interview with Amy Niles, in which she unpacks the "State of Patient Access and Affordability" breakout session she moderated at Informa Connect's PAP Conference 2024 last month.

In just a few minutes, Amy thoroughly yet succinctly explores the stark realities faced by adults with chronic conditions, from systemic barriers to accessing essential care to the alarming disparities among demographic groups.

Watch the interview:

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs

© 2024 MJH Life Sciences

All rights reserved.